2m 2m 2m 2m 2m 2m 2m
IMMIX BIOPHARMA (IMMX)
NASDAQ
$8.34-$0.01 (-0.18%)
Price as of Oct 22, 2026 7:30 PM EDT- $705.5MMarket Cap
- 175.40%1-Year Change
- BiotechnologyIndustry
IMMIX BIOPHARMA (IMMX)
$8.34-$0.01 (-0.18%)
IMMX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $8.35 | ||
Change | -$0.40 (-4.49%) | ||
Open | $8.40 | ||
High | $8.73 | ||
Low | $8.23 | ||
Previous Close | $8.51 | ||
Volume | 817,970 | ||
30-Day Average Volume | 1,627,482 | ||
1-Week Change | 0.00% | ||
1-Month Change | -31.76% | ||
1-Year Change | 175.40% | ||
3-Year Change | 188.47% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 82.9M | ||
Total Assets | $239.1M | ||
Market Cap | $705.5M | ||
Enterprise Value | $480.0M | ||
Period: QTR TTM FY | |||
Revenue | $20.0M | ||
Net Income | -$11.5M | ||
Free Cash Flow | -$11.8M | ||
EBIT | -$11.5M | ||
EBITDA | -$11.4M | ||
Net Working Capital | $224.5M | ||
EPS | -$0.18 | ||
Enterprise Value/EBITDA | -42 | ||
Enterprise Value/Revenue | 24 | ||
P/B | 3 | ||
P/E | -47 | ||
PEG | N/A | ||
Price/Free Cash Flow | -60 | ||
Price/Operating Cash Flow | -60 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue